Barinthus Biotherapeutics (BRNS) Change in Receivables (2020 - 2023)
Barinthus Biotherapeutics (BRNS) reported Change in Receivables of -$194000.0 for Q3 2023, up 98.21% on a YoY basis from -$97873.7 in Q3 2022, and up 69.92% quarter-over-quarter from -$645000.0 in Q2 2023.
Barinthus Biotherapeutics (BRNS) Change in Receivables (2020 - 2023) Analysis & Trends
Barinthus Biotherapeutics has reported Change in Receivables for 4 years, with the latest figure at -$194000.0 in Q3 2023.
- For the quarter ending Q3 2023, Change in Receivables rose 98.21% year-over-year to -$194000.0; the trailing twelve-month figure through Jun 2024 stood at -$194000.0 (up 98.85% YoY), and the FY2023 full-year result was -$5.8 million, down 199.43% from the prior year.
- Change in Receivables for Q3 2023 stood at -$194000.0, up from -$645000.0 in the prior quarter.
- The five-year high for Change in Receivables was $18.4 million in Q1 2022, with the low at -$10.9 million in Q3 2022.
- Historically, Change in Receivables has averaged -$67000.0 across 4 years, with a median of -$284000.0 in 2021.
- The largest YoY upside for Change in Receivables was 8923.08% in 2022 against a maximum downside of 181200.0% in 2022.
- Barinthus Biotherapeutics' Change in Receivables stood at $448000.0 in 2020, then plunged by 116.29% to -$73000.0 in 2021, then tumbled by 350.68% to -$329000.0 in 2022, then jumped by 41.03% to -$194000.0 in 2023.
- The last three Change in Receivables figures came in at -$194000.0 (Q3 2023), -$645000.0 (Q2 2023), and -$5.0 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -194,000.00 |
| Sep 30, 2023 | -194,000.00 |
| Jun 30, 2023 | -645,000.00 |
| Jun 30, 2023 | -645,000.00 |
| Mar 31, 2023 | -4.96 Mn |
| Mar 31, 2023 | -4.96 Mn |
| Dec 31, 2022 | -329,000.00 |
| Dec 31, 2022 | -329,000.00 |
| Sep 30, 2022 | -10.87 Mn |
| Sep 30, 2022 | -10.87 Mn |
| Jun 30, 2022 | -1.32 Mn |
| Jun 30, 2022 | -1.32 Mn |
| Mar 31, 2022 | 18.35 Mn |
| Mar 31, 2022 | 18.35 Mn |
| Dec 31, 2021 | -73,000.00 |
| Dec 31, 2021 | -73,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | -284,000.00 |
| Jun 30, 2021 | -284,000.00 |